UM

Browse/Search Results:  1-10 of 14 Help

Selected(0)Clear Items/Page:    Sort:
An “all-in-one” scaffold targeting macrophages to direct endogenous bone repair in situ Journal article
Acta Biomaterialia, 2020,Volume: 111,Page: 153-169
Authors:  Niu,Yiming;  Wang,Lintao;  Yu,Na;  Xing,Panfei;  Wang,Zhenzhen;  Zhong,Zhangfeng;  Feng,Yanxian;  Dong,Lei;  Wang,Chunming
Favorite |  | TC[WOS]:0 TC[Scopus]:1 | Submit date:2021/03/02
Bioactive scaffolds  Bone  Macrophages  Polysaccharides  Tissue regeneration  
Supramolecular Nano-Encapsulation of Anabasine Reduced Its Developmental Toxicity in Zebrafish Journal article
Frontiers in Chemistry, 2020,Volume: 8
Authors:  Gao,Yan;  Yang,Xue;  Wang,Ziyi;  Zhong,Zhangfeng;  Hu,Yuanjia;  Wang,Yitao
Favorite |  | TC[WOS]:0 TC[Scopus]:0 | Submit date:2021/03/01
anabasine  cucurbit[7]uril  supermolecular  toxicity  zebrafish  
CTLA-4 immunotherapy exposes differences in immune response along with different tumor progression in colorectal cancer Journal article
Aging, 2020,Volume: 12,Issue: 15,Page: 15656-15669
Authors:  Fu,Xiaocong;  Luo,Hua;  Zheng,Yuhui;  Wang,Shengpeng;  Zhong,Zhangfeng;  Wang,Yitao;  Yang,Yeguo
Favorite |  | TC[WOS]:0 TC[Scopus]:1 | Submit date:2021/03/02
Central memory T cell (TCM)  CTLA-4  Effector memory T cell (TEM)  Tumor-immune microenvironment  
Gambogic acid sensitizes breast cancer cells to TRAIL-induced apoptosis by promoting the crosstalk of extrinsic and intrinsic apoptotic signalings Journal article
Food and Chemical Toxicology, 2018,Volume: 119,Page: 334-341
Authors:  Wang,Shengpeng;  Xu,Yingqi;  Li,Chenyang;  Tao,Hongxun;  Wang,Anqi;  Sun,Chenyu;  Zhong,Zhangfeng;  Wu,Xu;  Li,Peng;  Wang,Yitao
Favorite |  | TC[WOS]:7 TC[Scopus]:8 | Submit date:2021/03/01
Apoptosis  Breast Cancer  Gambogic Acid  Resistance  Trail  
Gambogic acid sensitizes breast cancer cells to TRAIL-induced apoptosis by promoting the crosstalk of extrinsic and intrinsic apoptotic signalings Conference paper
FOOD AND CHEMICAL TOXICOLOGY, Kunming, PEOPLES R CHINA, AUG 25-30, 2018
Authors:  Wang, Shengpeng;  Xu, Yingqi;  Li, Chenyang;  Tao, Hongxun;  Wang, Anqi;  Sun, Chenyu;  Zhong, Zhangfeng;  Wu, Xu;  Li, Peng;  Wang, Yitao
Favorite |  | TC[WOS]:7 TC[Scopus]:8 | Submit date:2018/10/30
Trail  Gambogic Acid  Breast Cancer  Apoptosis  Resistance  
Anti-cancer effects of Rhizoma Curcumae against doxorubicin-resistant breast cancer cells Journal article
CHINESE MEDICINE, 2018,Volume: 13
Authors:  Zhong, Zhangfeng;  Yu, Haibing;  Wang, Shengpeng;  Wang, Yitao;  Cui, Liao
View | Adobe PDF | Favorite |  | TC[WOS]:7 TC[Scopus]:10 | Submit date:2018/10/30
Rhizoma Curcumae  Multidrug Resistance  Breast Cancer  Abc Transporters  Furanodiene  
Siegesbeckia pubescens Makino inhibits Pam(3)CSK(4)-induced inflammation in RAW 264.7 macrophages through suppressing TLR1/TLR2-mediated NF-kappa B activation Journal article
CHINESE MEDICINE, 2018,Volume: 13
Authors:  Sang, Wei;  Zhong, Zhangfeng;  Linghu, Kegang;  Xiong, Wei;  Tse, Anfernee Kai Wing;  Cheang, Wai San;  Yu, Hua;  Wang, Yitao
Favorite |  | TC[WOS]:16 TC[Scopus]:19 | Submit date:2018/10/30
Siegesbeckia Pubescens Makino  Pam(3)Csk(4)  Inflammation  Toll-like Receptor 1/2  Nf-kappa b  
Co-delivery of gambogic acid and TRAIL plasmid by hyaluronic acid grafted PEI-PLGA nanoparticles for the treatment of triple negative breast cancer Journal article
DRUG DELIVERY, 2017,Volume: 24,Issue: 1,Page: 1791-1800
Authors:  Wang, Shengpeng;  Shao, Min;  Zhong, Zhangfeng;  Wang, Anqi;  Cao, Jiliang;  Lu, Yucong;  Wang, Yitao;  Zhang, Jinming
View | Adobe PDF | Favorite |  | TC[WOS]:22 TC[Scopus]:22 | Submit date:2018/10/30
Nanoparticles  Trail  Gambogic Acid  Triple Negative Breast Cancer  Co-delivery  
The typical metabolic modifiers conferring improvement in cancer resistance Journal article
Current Medicinal Chemistry, 2017,Volume: 24,Issue: 34,Page: 3698-3710
Authors:  Tan,Wen;  Zhong,Zhangfeng;  Wang,Shengpeng;  Liu,Hui;  Yu,Hua;  Tan,Rui;  Hu,Xiaodong;  Pan,Tingrui;  Wang,Yitao
Favorite |  | TC[WOS]:9 TC[Scopus]:10 | Submit date:2021/03/02
2-deoxy-Dglucose  3-bromopyruvate  Cancer metabolic reprogramming  Cancer resistance  Lonidamine  Metabolic modifiers  
The Typical Metabolic Modifiers Conferring Improvement in Cancer Resistance Journal article
CURRENT MEDICINAL CHEMISTRY, 2017,Volume: 24,Issue: 34,Page: 3698-3710
Authors:  Tan, Wen;  Zhong, Zhangfeng;  Wang, Shengpeng;  Liu, Hui;  Yu, Hua;  Tan, Rui;  Hu, Xiaodong;  Pan, Tingrui;  Wang, Yitao
Favorite |  | TC[WOS]:9 TC[Scopus]:10 | Submit date:2018/10/30
Cancer Resistance  Cancer Metabolic Reprogramming  Metabolic Modifiers  Lonidamine  2-deoxy-d-glucose  3-bromopyruvate